SCHEMBL6845274

SCHEMBL6845274

CNC(C)c1ccc(C(=O)Nc2ccnc(Br)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.48
ROCK1 Q13464 2/20 0.48
AR P10275 4/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
KDM1A O60341 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
KLK7 P49862 1/20 0.41
NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6845275 0.84 ROCK2 (0.47) ROCK2ROCK1RAB9ANPC1KDM4E
SCHEMBL6845267 0.81 ROCK2 (0.71) ROCK2ROCK1RAB9ANPC1KDM4E
SCHEMBL6845277 0.81 ROCK2 (0.44) ROCK2ROCK1RAB9ANPC1ALDH1A1
SCHEMBL6845271 0.81 ROCK2 (0.44) ROCK2ROCK1RAB9ANPC1KDM4E
SCHEMBL24150224 0.78 JAK2 (0.60) ARRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL25306343 0.77 CA12 (0.53) ROCK2ROCK1ARRAB9ANPC1
SCHEMBL15238556 0.75 NPC1 (0.63) RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1
SCHEMBL16303150 0.73 AR (0.52) ARRAB9ANPC1KDM4EL3MBTL1
SCHEMBL73368 0.72 KDM4E (0.54) ARRAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL21146978 0.72 HDAC1 (0.65) HDAC1HDAC6SMN1; SMN2ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7867999-B1 Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions ALCON RESEARCH, LTD. (US) 2011-01-11 US disclosed